CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Vitamin Kdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00183001
NCT00183001Phase 3Completed
CompareCT.gov

Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification

National Institute on Aging (NIA)·interventional·Posted Sep 16, 2005·Updated Feb 16, 2009

In Brief

A Phase 3 clinical trial evaluating Vitamin K for Osteoporosis and 2 related conditions. Completed, across 1 site.

Detailed Summary

The purpose of this study is to determine if supplemental vitamin K will reduce age-related bone loss in elderly men and women above that achieved by supplementation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoporosis, Vascular Calcification, Inflammation
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI), Arthritis Foundation, USDA Beltsville Human Nutrition Research Center

Timeline

Phase 3CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 16, 2005
Enrollment StartOct 1, 2001
Study CompletionOct 1, 2006
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

Vitamin Kdrug